Pipeline

We have a robust pipeline focused on aging and fatal diseases in which short telomeres have causal or major exacerbating roles.  We are developing these programs in-house and through partnerships and out-licensing. 

In-Vivo Therapies

Rejuvenation Technologies Pipeline - In Vivo Therapies

Cell Therapies

Rejuvenation Technologies Pipeline - Cell Therapies

To find out about working with us or adding TERT mRNA to your cell therapy or therapeutic program, please complete our Co-Development Program application.